Berapa banyak dividen yang dibayarkan Sinphar Pharmaceutical Co 2024?
Berdasarkan data terkini dari Oktober 2024, Sinphar Pharmaceutical Co telah membayar dividen sejumlah total 1,00 TWD per saham dalam 12 bulan terakhir. Dengan kurs Sinphar Pharmaceutical Co saat ini sebesar 30,80 TWD, ini setara dengan yield dividen sebesar 3,25 %.
Dividen dibayarkan sebanyak kali per tahun.
3,25 % Dividen Yield | = | 1,00 TWD Dividen | 30,80 TWD Harga Saham |
|
Apakah dividen Sinphar Pharmaceutical Co aman?
Sinphar Pharmaceutical Co meningkatkan dividen sejak 1 tahun.
Dalam kurun waktu 10 tahun terakhir, Sinphar Pharmaceutical Co telah meningkatkan sebesar 6,471 % setiap tahunnya.
Dalam kurun waktu 5 tahun, naik pembagian dividen meningkat sebesar 37,973 %.
Analis memperkirakan untuk tahun fiskal yang sedang berjalan akan terjadi pertumbuhan sebesar Pengurangan dividen%.
Sinphar Pharmaceutical Co Aktienanalyse
Apa yang dilakukan Sinphar Pharmaceutical Co?
Sinphar Pharmaceutical Co Ltd is a Taiwanese company specializing in the pharmaceutical industry, founded in 1970. It is a leading manufacturer of pharmaceuticals and specializes in the production of generics and branded drugs.
The company is headquartered in Taipei, Taiwan and has become an important player in the global pharmaceutical market in recent years. It has several divisions specializing in the production of drugs, supplements, and medical devices.
Sinphar has two main business models, including the development of its own products and the licensing of products from other companies. The company has its own manufacturing facility, certified to FDA and GMP (Good Manufacturing Practice) standards, allowing it to produce high-quality drugs.
Sinphar offers a wide range of products, including pharmaceuticals, supplements, medical devices, and other health products. It also has a variety of products focusing on the treatment of diseases such as diabetes, cancer, heart disease, and other conditions.
The company has several divisions specializing in the development of drugs and medical devices. It also has an extensive research and development department focusing on the development of new drugs and medical devices. Sinphar works closely with various academic institutions and research institutes to stay updated on the latest developments in medicine and utilize the latest technologies.
The company has several subsidiaries, including ones in the USA, China, and Singapore. Through these subsidiaries, the company has access to various local markets and can sell its products worldwide.
Sinphar has received several awards and recognition for its work in recent years. In 2019, the company was awarded by the Taiwanese Ministry of Education for its exceptional performance in the development of medical devices and pharmaceutical products.
Overall, Sinphar Pharmaceutical Co Ltd is a leading player in the pharmaceutical industry with a long history of developing high-quality drugs and medical devices. It specializes in the production of generics and branded drugs and has several divisions specializing in the development of drugs and medical devices. With its subsidiaries and research and development department, the company is well positioned to continue growing and evolving in the future. Sinphar Pharmaceutical Co adalah salah satu perusahaan paling populer di Eulerpool.com.Rencana tabungan saham menawarkan kesempatan menarik bagi investor untuk membangun kekayaan jangka panjang. Salah satu keuntungan utamanya adalah efek rata-rata biaya: Dengan berinvestasi dalam jumlah tetap secara reguler ke dalam saham atau dana saham, otomatis anda akan membeli lebih banyak saham ketika harga rendah, dan lebih sedikit ketika harga tinggi. Hal ini dapat menghasilkan harga rata-rata per saham yang lebih menguntungkan seiring waktu. Selain itu, rencana tabungan saham juga memungkinkan investor kecil untuk mengakses saham-saham mahal, karena mereka dapat berpartisipasi dengan jumlah yang kecil. Investasi rutin juga mendukung strategi investasi yang disiplin dan membantu menghindari keputusan emosional, seperti membeli atau menjual secara impulsif. Di samping itu, investor juga mendapat manfaat dari potensi peningkatan nilai saham serta dari pembagian dividen, yang bisa direinvestasikan, meningkatkan efek bunga majemuk dan dengan demikian pertumbuhan dari modal yang diinvestasikan.